The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) is a clinical study sponsored by the National Heart, Lung, and Blood Institute (NHLBI). PrecISE's physician scientists are dedicated to researching better treatments for people living with severe asthma.
PrecISE is a clinical study that uses precision medicine for severe asthma. Precision medicine is an approach that targets treatments to defined subgroups of patients who share similar characteristics, for example, patients with a certain genetic variation or patients with high number of blood eosinophils. Eosinophils are a type of white blood cell that may contribute to asthma by causing inflammation in your respiratory system.
Researchers from over 30 locations across the US, as well as sites in Canada and the UK, are involved in PrecISE. See the map below. Click on a state for a list of study sites by city.